Table 3 Association between log-transformed serum BFRs and hypertension in subgroups stratified by age and BMI

lgPBDE28

2.40

1.73–3.32

<0.01**

1.31

0.75–2.28

0.34

0.53

lgPBDE47

1.35

1.02–1.8

0.04*

1.29

0.81–2.06

0.28

0.51

lgPBDE85

1.30

1.02–1.65

0.04*

1.21

0.79–1.84

0.38

0.80

lgPBDE99

1.17

0.92–1.48

0.21

1.15

0.78–1.69

0.49

0.46

lgPBDE100

1.41

1.07–1.86

0.02*

1.37

0.89–2.09

0.15

0.67

lgPBDE153

1.44

1.06–1.94

0.02*

1.83

1.23–2.72

<0.01**

0.96

lgPBDE154

1.31

1.00-1.71

0.06

1.18

0.78–1.79

0.43

0.64

lgPBDE209

1.19

0.84–1.69

0.33

1.12

0.65–1.93

0.69

0.86

lgPBB153

2.38

2.05–2.76

<0.01**

1.06

0.72–1.55

0.77

< 0.01**

BMI

BMI < 30

BMI ≥ 30

P-int

OR

CI

P value

OR

CI

P value

lgPBDE28

1.54

1.04–2.27

0.03*

0.87

0.59–1.3

0.50

0.05*

lgPBDE47

1.33

0.98–1.80

0.07

0.89

0.63–1.24

0.48

0.08

lgPBDE85

1.28

0.97–1.69

0.08

0.95

0.7–1.29

0.74

0.15

lgPBDE99

1.17

0.89–1.54

0.26

0.86

0.64–1.15

0.30

0.11

lgPBDE100

1.36

1.02–1.82

0.04*

1.11

0.81–1.53

0.51

0.36

lgPBDE153

1.33

1.01–1.75

0.04*

1.89

1.37–2.61

<0.01**

0.07

lgPBDE154

1.28

0.95–1.72

0.10

0.94

0.68–1.32

0.74

0.18

lgPBDE209

1.16

0.77–1.76

0.47

0.98

0.59–1.60

0.92

0.75

lgPBB153

1.18

0.94–1.47

0.16

0.91

0.68–1.22

0.53

0.06